Histologic and immunohistochemical characterization of thymic epithelial tumours in the dog †
Comprehensive transcriptome profiling of squamous cell carcinoma of horn in Bos indicus
Polymorphism of P53-Ets/AP1 transactivation region of MDM2 oncogene and its immunohistochemical analysis in canine tumours
Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection-site sarcoma: results in 21 cats
Reaction phenotyping of vinblastine metabolism in dogs
Canine pancreatic islet cell tumours secreting insulin-like growth factor type 2: a rare entity
Lymphangiosarcoma in 12 dogs: a case series (1998–2013)
Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation
Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia®) in tumour-bearing dogs: a phase I dose-finding study
Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues ‡
The current state and a perspective towards the future of osteosarcoma in dogs
β -Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour
The 5-lipoxygenase inhibitor tepoxalin induces oxidative damage and altered PTEN status prior to apoptosis in canine osteosarcoma cell lines
Antagonism of serotonin receptor 1B decreases viability and promotes apoptosis in the COS canine osteosarcoma cell line
Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma
Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns